Cytosorbents Corp expected to post a loss of 5 cents a share - Earnings Preview

Cytosorbents

05/08/2025 23:47

Cytosorbents Corp CTSO.OQ CTSO.O is expected to  show a fall in quarterly revenue when it reports  results on August 7 for the period ending June 30 2025

The Princeton New Jersey-based  company is expected to report a 6.7% decrease in revenue to $9.235 million from $9.89 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Cytosorbents Corp is for a loss of 5 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Cytosorbents Corp is $4.00, about 77.1% above its last closing price of $0.92

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.07
-0.07
-0.02
Beat
71.4
Dec. 31 2025
-0.06
-0.06
-0.14
Missed
-121.1
Sep. 30 2024
-0.06
-0.06
-0.04
Beat
36.8​
Jun. 30 2024
-0.09
-0.10
-0.08
Beat
17.9
​​Mar. 31 2024
-0.12
-0.12
-0.12
Met
0
Dec. 31 2023
-0.10
-0.14
-0.13
Beat
5.5​
Sep. 30 2023
-0.15
-0.14
-0.21
Missed
-52.2
Jun. 30 2023
-0.11
-0.11
-0.14
Missed
-24.4

This summary was machine generated August 5 at 22:47 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)